The findings of the observational study published in The BMJ suggest that if these results can be replicated, cholesterol-lowering drugs could be considered for preventing stroke among older populations.
A growing proportion of vascular events occur in the oldest people in high-income countries, the study authors write. In France, where the study was conducted, 43% of deaths from coronary heart disease and 49% of deaths from stroke occurred in people aged 85 years and older in 2010.
Most randomized controlled trials that are conducted to test cardiovascular drugs involve participants under the age of 70, however, meaning that the benefit of these drugs for older people who are widely affected by vascular events is still uncertain.
No comments:
Post a Comment